ARK Innovation’s investment team promises investors a front-row seat to the future, and its broad calls on technologies such as artificial intelligence, biotechnology, and robotics have often been directionally correct. However, it hasn’t shown a strong ability to identify the themes’ biggest winners while prudently managing the portfolio’s extreme risks.
American Beacon ARK Transformational Innovation Fund R6 Class ADNRX
- NAV / 1-Day Return 20.81 / −2.59 %
- Total Assets 159.2M
-
Adj. Expense Ratio
1.050%
- Expense Ratio 1.050%
- Distribution Fee Level High
- Share Class Type Retirement, Large
- Category Technology
- Investment Style Mid Growth
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.00
- Turnover 46%
USD | NAV as of Jun 10, 2026 | 1-Day Return as of Jun 10, 2026, 10:45 PM GMT+0
Morningstar’s Analysis ADNRX
Will ADNRX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the ADNRX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of ADNRX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 51.9
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Tesla Inc | 9.95 | 17M | Consumer Cyclical |
CRISPR Therapeutics AG | 6.07 | 10M | Healthcare |
Tempus AI Inc Class A common stock | 5.70 | 10M | Healthcare |
Advanced Micro Devices Inc | 5.16 | 9M | Technology |
Shopify Inc Registered Shs -A- Subord Vtg | 4.48 | 8M | Technology |
Robinhood Markets Inc Class A | 4.40 | 8M | Financial Services |
Coinbase Global Inc Ordinary Shares - Class A | 4.36 | 7M | Financial Services |
Roku Inc Class A | 4.05 | 7M | Communication Services |
Circle Internet Group Inc Ordinary Shares - Class A | 3.94 | 7M | Financial Services |
Beam Therapeutics Inc | 3.78 | 7M | Healthcare |
United States